Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapid Podocyte ablation Causes Acute Renal Tubule Cell Necrosis and Interstitial Fibrosis.

bioRxiv : the preprint server for biology·2026

Same author

Persistent activation of monocytes/macrophages and cell senescence in SIV-infected macaques on ART.

Frontiers in immunology·2026

Same author

Characterization of subchronic lung and brain consequences caused by mouse-adapted SARS-CoV-2 and influenza A infection of C57BL6 mice.

Frontiers in immunology·2026

Same author

Advancing dual gene therapy for SFTPC deficiency.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adults.

American journal of respiratory and critical care medicine·2026

Same author

Single-Cell RNA Sequencing Reveals Commensal Microbes Amplify Sex-Specific Immune Programming in the Murine Lung.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Jan 8, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

Segregating pneumonia into pneumotypes.

Anne E D'Armond¹, Jay K Kolls¹

¹Departments of Medicine and Pediatrics, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Cell Host & Microbe

|December 11, 2025

Summary

Researchers identified distinct lung microbial states, termed "pneumotypes," in pneumonia patients. These pneumotypes may predict patient outcomes and treatment effectiveness.

Area of Science:

Microbiology
Pulmonary Medicine
Systems Biology

Background:

Pneumonia is a significant cause of morbidity and mortality worldwide.
The lung microbiome's role in pneumonia pathogenesis is increasingly recognized.
Understanding microbial heterogeneity in the lung is crucial for effective treatment.

Purpose of the Study:

To define distinct microbial states (pneumotypes) in the lungs of pneumonia patients.
To investigate the association between pneumotypes and clinical outcomes.
To explore the potential of pneumotypes for predicting therapeutic success.

Main Methods:

Multi-omics analysis (e.g., metagenomics, metatranscriptomics) of bronchoalveolar lavage fluid.
Bioinformatic approaches to cluster microbial profiles.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Experiment Videos

Last Updated: Jan 8, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Correlation analysis with clinical data, including disease severity and treatment response.

Main Results:

Identification of several distinct pneumotypes characterized by specific microbial compositions and functions.
Significant differences in clinical outcomes and treatment responses were observed across different pneumotypes.
Certain pneumotypes were associated with poorer prognosis and reduced therapeutic efficacy.

Conclusions:

Lung microbial states (pneumotypes) represent a novel way to classify pneumonia.
Pneumotypes offer potential as biomarkers for predicting clinical trajectories and guiding therapeutic strategies.
Further research is warranted to validate these findings and translate them into clinical practice.